BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,000 | -12.5% | 5 | 0.0% | 0.00% | – |
| Q1 2022 | $24,000 | -52.0% | 5 | 0.0% | 0.00% | – |
| Q4 2021 | $50,000 | -47.9% | 5 | 0.0% | 0.00% | – |
| Q3 2021 | $96,000 | -33.3% | 5 | 0.0% | 0.00% | – |
| Q2 2021 | $144,000 | -4.6% | 5 | 0.0% | 0.00% | – |
| Q1 2021 | $151,000 | -30.1% | 5 | 0.0% | 0.00% | – |
| Q4 2020 | $216,000 | -20.0% | 5 | 0.0% | 0.00% | – |
| Q3 2020 | $270,000 | -11.5% | 5 | 0.0% | 0.00% | – |
| Q2 2020 | $305,000 | +32.6% | 5 | 0.0% | 0.00% | – |
| Q1 2020 | $230,000 | -50.9% | 5 | 0.0% | 0.00% | – |
| Q4 2019 | $468,000 | +2.0% | 5 | 0.0% | 0.00% | – |
| Q3 2019 | $459,000 | -27.8% | 5 | 0.0% | 0.00% | – |
| Q2 2019 | $636,000 | -19.1% | 5 | 0.0% | 0.00% | – |
| Q1 2019 | $786,000 | -97.7% | 5 | -98.6% | 0.00% | -100.0% |
| Q4 2018 | $34,412,000 | – | 347 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 5,910,687 | $24,470,000 | 3.71% |
| Monaco Asset Management SAM | 306,142 | $1,267,000 | 0.55% |
| Parametrica Management Ltd | 90,105 | $374,000 | 0.41% |
| Kamunting Street Capital Management, L.P. | 55,200 | $229,000 | 0.31% |
| Birchview Capital, LP | 98,000 | $406,000 | 0.30% |
| Kamunting Street Capital Management, L.P. | 35,000 | $145,000 | 0.20% |
| PDT Partners, LLC | 519,477 | $2,151,000 | 0.19% |
| Graham Capital Management, L.P. | 781,912 | $3,237,000 | 0.13% |
| CAXTON ASSOCIATES LP | 220,154 | $911,000 | 0.09% |
| Baker Brothers Advisors | 2,499,715 | $10,349,000 | 0.06% |